|Articles|June 24, 2020

Almac Group Launches Tempod 1000

Almac Clinical Services, part of the Almac Group, has launched Tempod 1000. Tempod 1000 is a USB device that captures and stores all clinical site temperature data and identifies unreported excursions once uploaded into TempEZ.

For more information, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Almac Group Launches Tempod 1000

Newsletter

Related Content

Reducing Site Burden Through Better Technology Integration in Clinical Trials

Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

Trending on Applied Clinical Trials Online

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

Reducing Site Burden Through Better Technology Integration in Clinical Trials

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use